STAT3 integrates cytokine and neurotrophin signals to promote sympathetic axon regeneration

Molecular and Cellular Neuroscience

Volumn 56, Issue , 2013, Pages 272-282

  Pellegrino, Michael J ^a   Habecker, Beth A ^a  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

Ciliary neurotrophic factor; Myocardial infarction; Nerve growth factor; Signal transducer and activator of transcription 3; Sympathetic axon regeneration

Indexed keywords

CYTOKINE; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; NEUROTROPHIN; SERINE; STAT3 PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; COMPLEMENT SYSTEM; CONTROLLED STUDY; FEMALE; GENETIC TRANSCRIPTION; GENETIC TRANSFECTION; HEART INFARCTION; IMMUNOCYTOCHEMISTRY; IN VITRO STUDY; MALE; NERVE FIBER REGENERATION; NEWBORN; NONHUMAN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; RAT; REAL TIME POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; SYMPATHETIC NERVE; SYMPATHETIC NERVE CELL; WESTERN BLOTTING;

BDNF; BRAIN-DERIVED NEUROTROPHIC FACTOR; CILIARY NEUROTROPHIC FACTOR; CNTF; DBH; DOPAMINE-Β-HYDROXYLASE; GLYCOPROTEIN 130; GP130; LEUKEMIA INHIBITORY FACTOR; LIF; MI; MYOCARDIAL INFARCTION; NERVE GROWTH FACTOR; NGF; SIGNAL TRANSDUCER AND ACTIVATOR OF TRANSCRIPTION 3; STAT3; SYMPATHETIC AXON REGENERATION; TRKA; TROPOMYOSINRELATED RECEPTOR KINASE A;

ADRENERGIC FIBERS; ANIMALS; AXONS; CELLS, CULTURED; CYTOKINES; MAP KINASE SIGNALING SYSTEM; MICE; MICE, INBRED C57BL; MICROTUBULES; NERVE GROWTH FACTOR; NERVE REGENERATION; PROTEIN BINDING; RATS; RATS, SPRAGUE-DAWLEY; STAT3 TRANSCRIPTION FACTOR; TRANSCRIPTION, GENETIC;

EID: 84880940533     PISSN: 10447431     EISSN: 10959327     Source Type: Journal    
DOI: 10.1016/j.mcn.2013.06.005     Document Type: Article

References (75)

1. Abe T., Morgan D.A., Gutterman D.D. Protective role of nerve growth factor against postischemic dysfunction of sympathetic coronary innervation. Circulation 1997, 95:213-220.
2. Adler R. Ciliary neurotrophic factor as an injury factor. Curr. Opin. Neurobiol. 1993, 3:785-789.
3. Alston E.N., Parrish D.C., Hasan W., Tharp K., Pahlmeyer L., Habecker B.A. Cardiac ischemia-reperfusion regulates sympathetic neuropeptide expression through gp130-dependent and independent mechanisms. Neuropeptides 2011, 45:33-42.
4. Aoyama T., Takimoto Y., Pennica D., Inoue R., Shinoda E., Hattori R., Yui Y., Sasayama S. Augmented expression of cardiotrophin-1 and its receptor component, gp130, in both left and right ventricles after myocardial infarction in the rat. J. Mol. Cell. Cardiol. 2000, 32:1821-1830.
5. Barber M.J., Mueller T.M., Henry D.P., Felten S.Y., Zipes D.P. Transmural myocardial infarction in the dog produces sympathectomy in noninfarcted myocardium. Circulation 1983, 67:787-796.
6. Bareyre F.M., Garzorz N., Lang C., Misgeld T., Buning H., Kerschensteiner M. In vivo imaging reveals a phase-specific role of STAT3 during central and peripheral nervous system axon regeneration. Proc. Natl. Acad. Sci. U. S. A. 2011, 108:6282-6287.
7. Ben-Yaakov K., Dagan S.Y., Segal-Ruder Y., Shalem O., Vuppalanchi D., Willis D.E., Yudin D., Rishal I., Rother F., Bader M., Blesch A., Pilpel Y., Twiss J.L., Fainzilber M. Axonal transcription factors signal retrogradely in lesioned peripheral nerve. EMBO J. 2012, 31:1350-1363.
8. Cafferty W.B., Gardiner N.J., Gavazzi I., Powell J., McMahon S.B., Heath J.K., Munson J., Cohen J., Thompson S.W. Leukemia inhibitory factor determines the growth status of injured adult sensory neurons. J. Neurosci. 2001, 21:7161-7170.
9. Corness J., Stevens B., Fields R.D., Hokfelt T. NGF and LIF both regulate galanin gene expression in primary DRG cultures. Neuroreport 1998, 9:1533-1536.
10. Curmi P.A., Gavet O., Charbaut E., Ozon S., Lachkar-Colmerauer S., Manceau V., Siavoshian S., Maucuer A., Sobel A. Stathmin and its phosphoprotein family: general properties, biochemical and functional interaction with tubulin. Cell Struct. Funct. 1999, 24:345-357.
11. Ekstrom P.A., Kerekes N., Hokfelt T. Leukemia inhibitory factor null mice: unhampered in vitro outgrowth of sensory axons but reduced stimulatory potential by nerve segments. Neurosci. Lett. 2000, 281:107-110.
12. Fischer P., Hilfiker-Kleiner D. Survival pathways in hypertrophy and heart failure: the gp130-STAT axis. Basic Res. Cardiol. 2007, 102:393-411.
13. Frangogiannis N.G., Smith C.W., Entman M.L. The inflammatory response in myocardial infarction. Cardiovasc. Res. 2002, 53:31-47.
14. Gardner R.T., Habecker B.A. Infarct-derived chondroitin sulfate proteoglycans prevent sympathetic reinnervation after cardiac ischemia-reperfusion injury. J. Neurosci. 2013, 33:7175-7183.
15. Gavet O., Ozon S., Manceau V., Lawler S., Curmi P., Sobel A. The stathmin phosphoprotein family: intracellular localization and effects on the microtubule network. J. Cell Sci. 1998, 111(Pt 22):3333-3346.
16. Ghilardi J.R., Freeman K.T., Jimenez-Andrade J.M., Coughlin K.A., Kaczmarska M.J., Castaneda-Corral G., Bloom A.P., Kuskowski M.A., Mantyh P.W. Neuroplasticity of sensory and sympathetic nerve fibers in a mouse model of a painful arthritic joint. Arthritis Rheum. 2012, 64:2223-2232.
17. Glebova N.O., Ginty D.D. Growth and survival signals controlling sympathetic nervous system development. Annu. Rev. Neurosci. 2005, 28:191-222.
18. Gloster A., Diamond J. Sympathetic nerves in adult rats regenerate normally and restore pilomotor function during an anti-NGF treatment that prevents their collateral sprouting. J. Comp. Neurol. 1992, 326:363-374.
19. Gloster A., Diamond J. NGF-dependent and NGF-independent recovery of sympathetic function after chemical sympathectomy with 6-hydroxydopamine. J. Comp. Neurol. 1995, 359:586-594.
20. Gwechenberger M., Mendoza L.H., Youker K.A., Frangogiannis N.G., Smith C.W., Michael L.H., Entman M.L. Cardiac myocytes produce interleukin-6 in culture and in viable border zone of reperfused infarctions. Circulation 1999, 99:546-551.
21. Habecker B.A., Sachs H.H., Rohrer H., Zigmond R.E. The dependence on gp130 cytokines of axotomy induced neuropeptide expression in adult sympathetic neurons. Dev. Neurobiol. 2009, 69:392-400.
22. Hasan W., Jama A., Donohue T., Wernli G., Onyszchuk G., Al-Hafez B., Bilgen M., Smith P.G. Sympathetic hyperinnervation and inflammatory cell NGF synthesis following myocardial infarction in rats. Brain Res. 2006, 1124:142-154.
23. Hilfiker-Kleiner D., Shukla P., Klein G., Schaefer A., Stapel B., Hoch M., Muller W., Scherr M., Theilmeier G., Ernst M., Hilfiker A., Drexler H. Continuous glycoprotein-130-mediated signal transducer and activator of transcription-3 activation promotes inflammation, left ventricular rupture, and adverse outcome in subacute myocardial infarction. Circulation 2010, 122:145-155.
24. Hiltunen J.O., Laurikainen A., Vakeva A., Meri S., Saarma M. Nerve growth factor and brain-derived neurotrophic factor mRNAs are regulated in distinct cell populations of rat heart after ischaemia and reperfusion. J. Pathol. 2001, 194:247-253.
25. Homs J., Ariza L., Pages G., Udina E., Navarro X., Chillon M., Bosch A. Schwann cell targeting via intrasciatic injection of AAV8 as gene therapy strategy for peripheral nerve regeneration. Gene Ther. 2011, 18:622-630.
26. Hyatt Sachs H., Schreiber R.C., Shoemaker S.E., Sabe A., Reed E., Zigmond R.E. Activating transcription factor 3 induction in sympathetic neurons after axotomy: response to decreased neurotrophin availability. Neuroscience 2007, 150:887-897.
27. Hyatt Sachs H., Rohrer H., Zigmond R.E. The conditioning lesion effect on sympathetic neurite outgrowth is dependent on gp130 cytokines. Exp. Neurol. 2010, 223:516-522.
28. Ichiba M., Nakajima K., Yamanaka Y., Kiuchi N., Hirano T. Autoregulation of the Stat3 gene through cooperation with a cAMP-responsive element-binding protein. J. Biol. Chem. 1998, 273:6132-6138.
29. Inoue H., Zipes D.P. Time course of denervation of efferent sympathetic and vagal nerves after occlusion of the coronary artery in the canine heart. Circ. Res. 1988, 62:1111-1120.
30. Ip N.Y., Nye S.H., Boulton T.G., Davis S., Taga T., Li Y., Birren S.J., Yasukawa K., Kishimoto T., Anderson D.J., et al. CNTF and LIF act on neuronal cells via shared signaling pathways that involve the IL-6 signal transducing receptor component gp130. Cell 1992, 69:1121-1132.
31. Lee N., Neitzel K.L., Devlin B.K., MacLennan A.J. STAT3 phosphorylation in injured axons before sensory and motor neuron nuclei: potential role for STAT3 as a retrograde signaling transcription factor. J. Comp. Neurol. 2004, 474:535-545.
32. Leibinger M., Muller A., Andreadaki A., Hauk T.G., Kirsch M., Fischer D. Neuroprotective and axon growth-promoting effects following inflammatory stimulation on mature retinal ganglion cells in mice depend on ciliary neurotrophic factor and leukemia inhibitory factor. J. Neurosci. 2009, 29:14334-14341.
33. Levy D.E., Darnell J.E. Stats: transcriptional control and biological impact. Nat. Rev. Mol. Cell Biol. 2002, 3:651-662.
34. Liu R.Y., Snider W.D. Different signaling pathways mediate regenerative versus developmental sensory axon growth. J. Neurosci. 2001, 21:RC164.
35. Lorentz C.U., Alston E.N., Belcik T., Lindner J.R., Giraud G.D., Habecker B.A. Heterogeneous ventricular sympathetic innervation, altered beta-adrenergic receptor expression, and rhythm instability in mice lacking the p75 neurotrophin receptor. Am. J. Physiol. Heart Circ. Physiol. 2010, 298:H1652-H1660.
36. McQuarrie I.G., Grafstein B. Axon outgrowth enhanced by a previous nerve injury. Arch. Neurol. 1973, 29:53-55.
37. Meloni M., Caporali A., Graiani G., Lagrasta C., Katare R., Van Linthout S., Spillmann F., Campesi I., Madeddu P., Quaini F., Emanueli C. Nerve growth factor promotes cardiac repair following myocardial infarction. Circ. Res. 2010, 106:1275-1284.
38. Miao T., Wu D., Zhang Y., Bo X., Subang M.C., Wang P., Richardson P.M. Suppressor of cytokine signaling-3 suppresses the ability of activated signal transducer and activator of transcription-3 to stimulate neurite growth in rat primary sensory neurons. J. Neurosci. 2006, 26:9512-9519.
39. Navarro X., Kennedy W.R. The effect of a conditioning lesion on sudomotor axon regeneration. Brain Res. 1990, 509:232-236.
40. Ng Y.P., He W., Ip N.Y. Leukemia inhibitory factor receptor signaling negatively modulates nerve growth factor-induced neurite outgrowth in PC12 cells and sympathetic neurons. J. Biol. Chem. 2003, 278:38731-38739.
41. Ng D.C., Lin B.H., Lim C.P., Huang G., Zhang T., Poli V., Cao X. Stat3 regulates microtubules by antagonizing the depolymerization activity of stathmin. J. Cell Biol. 2006, 172:245-257.
42. Ng Y.P., Cheung Z.H., Ip N.Y. STAT3 as a downstream mediator of Trk signaling and functions. J. Biol. Chem. 2006, 281:15636-15644.
43. Nicolas C.S., Peineau S., Amici M., Csaba Z., Fafouri A., Javalet C., Collett V.J., Hildebrandt L., Seaton G., Choi S.L., Sim S.E., Bradley C., Lee K., Zhuo M., Kaang B.K., Gressens P., Dournaud P., Fitzjohn S.M., Bortolotto Z.A., Cho K., Collingridge G.L. The Jak/STAT pathway is involved in synaptic plasticity. Neuron 2012, 73:374-390.
44. O'Brien J.J., Nathanson N.M. Retrograde activation of STAT3 by leukemia inhibitory factor in sympathetic neurons. J. Neurochem. 2007, 103:288-302.
45. Ozon S., El Mestikawy S., Sobel A. Differential, regional, and cellular expression of the stathmin family transcripts in the adult rat brain. J. Neurosci. Res. 1999, 56:553-564.
46. Parrish D.C., Alston E.N., Rohrer H., Hermes S.M., Aicher S.A., Nkadi P., Woodward W.R., Stubbusch J., Gardner R.T., Habecker B.A. Absence of gp130 in dopamine beta-hydroxylase-expressing neurons leads to autonomic imbalance and increased reperfusion arrhythmias. Am. J. Physiol. Heart Circ. Physiol. 2009, 297:H960-H967.
47. Pellegrino M.J., Parrish D.C., Zigmond R.E., Habecker B.A. Cytokines inhibit norepinephrine transporter expression by decreasing Hand2. Mol. Cell. Neurosci. 2011, 46:671-680.
48. Qiu J., Cafferty W.B., McMahon S.B., Thompson S.W. Conditioning injury-induced spinal axon regeneration requires signal transducer and activator of transcription 3 activation. J. Neurosci. 2005, 25:1645-1653.
49. Rajan P., Gearan T., Fink J.S. Leukemia inhibitory factor and NGF regulate signal transducers and activators of transcription activation in sympathetic ganglia: convergence of cytokine- and neurotrophin-signaling pathways. Brain Res. 1998, 802:198-204.
50. Rao M.S., Sun Y., Escary J.L., Perreau J., Tresser S., Patterson P.H., Zigmond R.E., Brulet P., Landis S.C. Leukemia inhibitory factor mediates an injury response but not a target-directed developmental transmitter switch in sympathetic neurons. Neuron 1993, 11:1175-1185.
51. Roger V.L., Go A.S., Lloyd-Jones D.M., Benjamin E.J., Berry J.D., Borden W.B., Bravata D.M., Dai S., Ford E.S., Fox C.S., Fullerton H.J., Gillespie C., Hailpern S.M., Heit J.A., Howard V.J., Kissela B.M., Kittner S.J., Lackland D.T., Lichtman J.H., Lisabeth L.D., Makuc D.M., Marcus G.M., Marelli A., Matchar D.B., Moy C.S., Mozaffarian D., Mussolino M.E., Nichol G., Paynter N.P., Soliman E.Z., Sorlie P.D., Sotoodehnia N., Turan T.N., Virani S.S., Wong N.D., Woo D., Turner M.B., American Heart Association Statistics C, Stroke Statistics S Heart disease and stroke statistics-2012 update: a report from the American Heart Association. Circulation 2012, 125:e2-e220.
52. Ruit K.G., Osborne P.A., Schmidt R.E., Johnson E.M., Snider W.D. Nerve growth factor regulates sympathetic ganglion cell morphology and survival in the adult mouse. J. Neurosci. 1990, 10:2412-2419.
53. Schust J., Sperl B., Hollis A., Mayer T.U., Berg T. Stattic: a small-molecule inhibitor of STAT3 activation and dimerization. Chem. Biol. 2006, 13:1235-1242.
54. Selvaraj B.T., Frank N., Bender F.L., Asan E., Sendtner M. Local axonal function of STAT3 rescues axon degeneration in the pmn model of motoneuron disease. J. Cell Biol. 2012, 199:437-451.
55. Shadiack A.M., Vaccariello S.A., Sun Y., Zigmond R.E. Nerve growth factor inhibits sympathetic neurons' response to an injury cytokine. Proc. Natl. Acad. Sci. U. S. A. 1998, 95:7727-7730.
56. Shadiack A.M., Sun Y., Zigmond R.E. Nerve growth factor antiserum induces axotomy-like changes in neuropeptide expression in intact sympathetic and sensory neurons. J. Neurosci. 2001, 21:363-371.
57. Shi X., Habecker B.A. gp130 cytokines stimulate proteasomal degradation of tyrosine hydroxylase via extracellular signal regulated kinases 1 and 2. J. Neurochem. 2012, 120:239-247.
58. Shin J.E., Cho Y., Beirowski B., Milbrandt J., Cavalli V., DiAntonio A. Dual leucine zipper kinase is required for retrograde injury signaling and axonal regeneration. Neuron 2012, 74:1015-1022.
59. Shoemaker S.E., Sachs H.H., Vaccariello S.A., Zigmond R.E. A conditioning lesion enhances sympathetic neurite outgrowth. Exp. Neurol. 2005, 194:432-443.
60. Smith D.S., Skene J.H. A transcription-dependent switch controls competence of adult neurons for distinct modes of axon growth. J. Neurosci. 1997, 17:646-658.
61. Smith P.D., Sun F., Park K.K., Cai B., Wang C., Kuwako K., Martinez-Carrasco I., Connolly L., He Z. SOCS3 deletion promotes optic nerve regeneration in vivo. Neuron 2009, 64:617-623.
62. Sofroniew M.V., Howe C.L., Mobley W.C. Nerve growth factor signaling, neuroprotection, and neural repair. Annu. Rev. Neurosci. 2001, 24:1217-1281.
63. Stanke M., Duong C.V., Pape M., Geissen M., Burbach G., Deller T., Gascan H., Otto C., Parlato R., Schutz G., Rohrer H. Target-dependent specification of the neurotransmitter phenotype: cholinergic differentiation of sympathetic neurons is mediated in vivo by gp 130 signaling. Development 2006, 133:141-150.
64. Sun Y., Rao M.S., Zigmond R.E., Landis S.C. Regulation of vasoactive intestinal peptide expression in sympathetic neurons in culture and after axotomy: the role of cholinergic differentiation factor/leukemia inhibitory factor. J. Neurobiol. 1994, 25:415-430.
65. Sun F., Park K.K., Belin S., Wang D., Lu T., Chen G., Zhang K., Yeung C., Feng G., Yankner B.A., He Z. Sustained axon regeneration induced by co-deletion of PTEN and SOCS3. Nature 2011, 480:372-375.
66. Taga T. Gp130, a shared signal transducing receptor component for hematopoietic and neuropoietic cytokines. J. Neurochem. 1996, 67:1-10.
67. Taga T., Kishimoto T. Gp130 and the interleukin-6 family of cytokines. Annu. Rev. Immunol. 1997, 15:797-819.
68. Vaseghi M., Lux R.L., Mahajan A., Shivkumar K. Sympathetic stimulation increases dispersion of repolarization in humans with myocardial infarction. Am. J. Physiol. Heart Circ. Physiol. 2012, 302:H1838-H1846.
69. Verma N.K., Dourlat J., Davies A.M., Long A., Liu W.Q., Garbay C., Kelleher D., Volkov Y. STAT3-stathmin interactions control microtubule dynamics in migrating T-cells. J. Biol. Chem. 2009, 284:12349-12362.
70. Walker S.R., Chaudhury M., Nelson E.A., Frank D.A. Microtubule-targeted chemotherapeutic agents inhibit signal transducer and activator of transcription 3 (STAT3) signaling. Mol. Pharmacol. 2010, 78:903-908.
71. Weidler M., Rether J., Anke T., Erkel G. Inhibition of interleukin-6 signaling by galiellalactone. FEBS Lett. 2000, 484:1-6.
72. Wernli G., Hasan W., Bhattacherjee A., van Rooijen N., Smith P.G. Macrophage depletion suppresses sympathetic hyperinnervation following myocardial infarction. Basic Res. Cardiol. 2009, 104:681-693.
73. Zhou F.Q., Snider W.D. Intracellular control of developmental and regenerative axon growth. Philos. Trans. R. Soc. Lond. B Biol. Sci. 2006, 361:1575-1592.
74. Zhou L., Too H.P. Mitochondrial localized STAT3 is involved in NGF induced neurite outgrowth. PLoS One 2011, 6:e21680.
75. Zhou S., Chen L.S., Miyauchi Y., Miyauchi M., Kar S., Kangavari S., Fishbein M.C., Sharifi B., Chen P.S. Mechanisms of cardiac nerve sprouting after myocardial infarction in dogs. Circ. Res. 2004, 95:76-83.